In recent years, the p38 MAPK has emerged as a key signaling molecule in the regulation of cancer invasion and metastasis by modulating the expression and activity of molecules governing the degradation of extracellular matrix (that is, urokinase plasminogen activator, MMP-2, and MMP-9) [22-25,45]. The gene discussed is PLAU; the disease is cancer.